Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Steinbach

Showing results (221-230 of 369) with videos related to

Pageof 37
Sort By:
Genomics|July 1, 1991
Linkage homogeneity near the fragile X locus in normal and fragile X familiesG K Suthers, J C Mulley, M A Voelckel, et al.
Frontiers in Immunology|January 20, 2022
Immune Checkpoint Inhibitor-Induced Cerebral Pseudoprogression: Patterns and CategorizationHans Urban, Eike Steidl, Elke Hattingen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2007
Combined 1p/19q loss in oligodendroglial tumors: predictive or prognostic biomarker?Michael Weller, Hilmar Berger, Christian Hartmann, et al.
International Journal of Oncology|May 4, 2012
PAX2 is an antiapoptotic molecule with deregulated expression in medulloblastomaM C Burger, D P Brucker, P Baumgarten, et al.
American Journal of Human Genetics|March 1, 1991
Genetic mapping of new DNA probes at Xq27 defines a strategy for DNA studies in the fragile X syndromeG K Suthers, J C Mulley, M A Voelckel, et al.
Neuro-Oncology Advances|November 29, 2023
Gliomatosis cerebri (GC) growth pattern: A single-center analysis of clinical, histological, and molecular characteristics of GC and non-GC glioblastomaIris Divé, Katharina J Weber, Tabea I Hartung, et al.
Clinical Nuclear Medicine|March 3, 2025
Somatostatin Receptor-Directed Theranostics in EsthesioneuroblastomaYingjun Zhi, Sebastian E Serfling, Daniel Groener, et al.
Journal of Magnetic Resonance Imaging : JMRI|May 9, 2024
2D <sup>1</sup>H sLASER Long-TE and 3D <sup>31</sup>P Chemical Shift Imaging at 3 T for Monitoring Fasting-Induced Changes in Brain Tumor TissueSeyma Alcicek, Iris Divé, Dennis C Thomas, et al.
Journal of Neuro-Oncology|October 3, 2023
The proneural subtype is not associated with survival benefit from bevacizumab in newly diagnosed glioblastoma: a secondary analysis of the GLARIUS trialJohannes Weller, Thomas Zeyen, Niklas Schäfer, et al.
Oncotarget|May 13, 2015
Perioperative cerebral ischemia promote infiltrative recurrence in glioblastomaAnna-Luisa Thiepold, Sebastian Luger, Marlies Wagner, et al.
Pageof 37

Showing results (221-230 of 369) with videos related to

Sort By:
Pageof 37
Genomics|July 1, 1991
Linkage homogeneity near the fragile X locus in normal and fragile X familiesG K Suthers, J C Mulley, M A Voelckel, et al.
Frontiers in Immunology|January 20, 2022
Immune Checkpoint Inhibitor-Induced Cerebral Pseudoprogression: Patterns and CategorizationHans Urban, Eike Steidl, Elke Hattingen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2007
Combined 1p/19q loss in oligodendroglial tumors: predictive or prognostic biomarker?Michael Weller, Hilmar Berger, Christian Hartmann, et al.
International Journal of Oncology|May 4, 2012
PAX2 is an antiapoptotic molecule with deregulated expression in medulloblastomaM C Burger, D P Brucker, P Baumgarten, et al.
American Journal of Human Genetics|March 1, 1991
Genetic mapping of new DNA probes at Xq27 defines a strategy for DNA studies in the fragile X syndromeG K Suthers, J C Mulley, M A Voelckel, et al.
Neuro-Oncology Advances|November 29, 2023
Gliomatosis cerebri (GC) growth pattern: A single-center analysis of clinical, histological, and molecular characteristics of GC and non-GC glioblastomaIris Divé, Katharina J Weber, Tabea I Hartung, et al.
Clinical Nuclear Medicine|March 3, 2025
Somatostatin Receptor-Directed Theranostics in EsthesioneuroblastomaYingjun Zhi, Sebastian E Serfling, Daniel Groener, et al.
Journal of Magnetic Resonance Imaging : JMRI|May 9, 2024
2D <sup>1</sup>H sLASER Long-TE and 3D <sup>31</sup>P Chemical Shift Imaging at 3 T for Monitoring Fasting-Induced Changes in Brain Tumor TissueSeyma Alcicek, Iris Divé, Dennis C Thomas, et al.
Journal of Neuro-Oncology|October 3, 2023
The proneural subtype is not associated with survival benefit from bevacizumab in newly diagnosed glioblastoma: a secondary analysis of the GLARIUS trialJohannes Weller, Thomas Zeyen, Niklas Schäfer, et al.
Oncotarget|May 13, 2015
Perioperative cerebral ischemia promote infiltrative recurrence in glioblastomaAnna-Luisa Thiepold, Sebastian Luger, Marlies Wagner, et al.
Pageof 37